Patient-Friendly Explanation
DPP-4 inhibitors are oral tablets used to manage type 2 diabetes by helping the body release the right amount of insulin after meals. They are known for being gentle on blood sugar levels and, importantly, they do not cause weight gain like some other diabetes medicines. Many people find them easy to take as part of their daily routine.
Clinical Definition
DPP-4 inhibitors (e.g., sitagliptin, linagliptin) block the enzyme dipeptidyl peptidase-4, prolonging the action of incretin hormones such as GLP-1. This enhances glucose-dependent insulin secretion and suppresses glucagon release, improving glycaemic control with a weight-neutral profile and low hypoglycaemia risk.
Why It Matters
For patients with prediabetes or type 2 diabetes who are also trying to lose weight, DPP-4 inhibitors offer effective glucose control without adding to the scale. NuLifeCare Singapore considers weight-friendly options like these when building personalised medical weight management plans.